• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The genomic and epigenomic landscape in thymic carcinoma

Research Project

Project/Area Number 26461206
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Respiratory organ internal medicine
Research InstitutionNational Cancer Center Japan

Principal Investigator

Fujiwara Yutaka  国立研究開発法人国立がん研究センター, 中央病院, 医長 (70464261)

Research Collaborator Asao Tetsuhiko  
Kohno Takashi  
Ichikawa Hitoshi  
Saito Motonobu  
Project Period (FY) 2014-04-01 – 2017-03-31
Project Status Completed (Fiscal Year 2016)
Budget Amount *help
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2015: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2014: ¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Keywords胸腺癌 / 化学療法 / 遺伝子Profile / 次世代シークエンサー / thymic carcinoma / TET2 / DNA methylation / 胸腺がん / がん遺伝子 / 遺伝子増幅 / 遺伝子変異 / 遺伝子癒合 / 遺伝子融合
Outline of Final Research Achievements

The aim of this study is to investigate the genomic and epigenomic alterations by next generation sequencing of thymic cancer as target for anti-cancer therapy. Sixty-four consecutive patients with thymic carcinoma treatedat the National Cancer Hospital between 1973 and 2014 were included in this study.
Tissue samples of 52 patients (81.3%) were available for targeted sequencing of mutation hot spots in 50cancer-related genes by IonAmpliseq Cancer Hotspot Panel v2. The genetic alterations of TP53, KRAS, FBXW7, and NRAS were detected in 7 patients (13.5%). In whole exome and transcriptome sequencing from paired snap-frozen cancerous or non-cancerous tissues (n=10), we identified a mutation signature consisting of enrichment for C>T substitutions at CpG dinucleotides. And we also identifies thymic cancers with TET2 mutations had more hypermethylated genes than those without, and hyper-methylation was associated with downregulation of gene expression.

Report

(4 results)
  • 2016 Annual Research Report   Final Research Report ( PDF )
  • 2015 Research-status Report
  • 2014 Research-status Report
  • Research Products

    (2 results)

All 2016 2015

All Journal Article (1 results) (of which Peer Reviewed: 1 results,  Acknowledgement Compliant: 1 results) Presentation (1 results)

  • [Journal Article] Medical treatment involving investigational drugs and genetic profile of thymic carcinoma.2016

    • Author(s)
      Asao T, Fujiwara Y, Sunami K, Kitahara S, Goto Y, Kanda S, Horinouchi H, Nokihara H, Yamamoto N, Ichikawa H, Kohno T, Tsuta K, Watanabe S, Takahashi K, Ohe Y.
    • Journal Title

      Lung Cancer

      Volume: 93 Pages: 77-81

    • DOI

      10.1016/j.lungcan.2016.01.004

    • Related Report
      2016 Annual Research Report 2015 Research-status Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Presentation] Retrospective analysis of 64 consecutive patients with thymic cancer2015

    • Author(s)
      Tetsuhiko Asao, Yutaka Fujiwara, Kuniko Sunami, Shinsuke Kitahara, Shintaro Kanda, Hidehito Horinouchi, Hiroshi Nokihara, Noboru Yamamoto, Reika Iwakawa-Kawabata, Takashi Kohno, Koji Tsuta, Shun-ichi Watanabe, Hisao Asanuma, and Yuichiro Ohe
    • Organizer
      第112回日本内科学会
    • Place of Presentation
      京都
    • Year and Date
      2015-04-10
    • Related Report
      2015 Research-status Report

URL: 

Published: 2014-04-04   Modified: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi